Longevity News

TREM2 as a Central Hub of Neuroimmune-Metabolic Crosstalk in Central Nervous System Disorders: From Microglial Biology to Therapeutic Targeting

Source: Frontiers - Health • Published: 07 Aug 2026, 00:00

TREM2 as a Central Hub of Neuroimmune-Metabolic Crosstalk in Central Nervous System Disorders: From Microglial Biology to Therapeutic Targeting

A review synthesizing evidence that TREM2 coordinates microglial immune, metabolic, and phagocytic programs across diverse CNS disorders and therapeutic strategies.

Key Takeaways
  • You have multiple emails registered with Frontiers: You don't have a Frontiers account ?
  • You can register here Triggering receptor expressed on myeloid cells 2 (TREM2)
  • This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY)
Read Original Source

Continue exploring

Related longevity signals

Fight Aging!Senescent Cells in Metabolic DisordersReview of how senescent cells and their inflammatory secretions interact with metabolic dysfunction and drive diseases like fatty liver and diabetes.Frontiers - HealthRevisiting macrophage metabolic reprogramming in metabolic dysfunction-associated steatotic liver disease: mechanisms, regulation, and therapeutic breakthroughsMacrophage metabolic reprogramming in fatty liver disease — a review article guiding readers through mechanisms, regulatory circuits, and therapeutic research directions.Nature - BiotechnologyFrom natural vesicles to intelligent carriers: the metabolic basis and biomedical applications of lemon-derived extracellular vesiclesReview of lemon-derived extracellular vesicles covering isolation methods, molecular composition, bioactivities, and potential biomedical uses.Longevity TechnologyAI hunts new uses for Phase 3 metabolic drugAn AI-driven reverse‑engineering approach mines existing pharmacology and gene expression data to reveal additional disease targets for a late‑stage metabolic drug.